{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,5]],"date-time":"2026-04-05T19:43:09Z","timestamp":1775418189572,"version":"3.50.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T00:00:00Z","timestamp":1668124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T00:00:00Z","timestamp":1668124800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2023,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>To compare tear film osmolarity (TFO) values and matrix metalloproteinase 9 (MMP-9) levels between anophthalmic sockets and healthy fellow eyes and to assess the use of the MMP-9 and TFO as objective biomarkers for the dry anophthalmic socket syndrome (DASS).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In this prospective single-center study, the anophthalmic sockets and healthy fellow eyes of 98 unilateral anophthalmic patients were assessed using the ocular surface disease index (OSDI) questionnaire, InflammaDry\u00ae MMP-9 point-of-care immunoassay, TFO with TearLab\u2122 Osmolarity System, and clinical conjunctival inflammation. MMP-9 concentration and conjunctival inflammation were graded semi-quantitatively. Differences between anophthalmic sockets and the healthy fellow eyes for OSDI scores, MMP-9, TFO values, clinical conjunctival inflammation, and eyelid abnormalities as well as the correlation between these factors and demographic data were evaluated.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Patients had significantly higher OSDI, MMP-9, and TFO values, as well as higher conjunctival inflammation on the anophthalmic side, compared to the healthy side (<jats:italic>p<\/jats:italic>\u2009\u2264\u20090.002, respectively). For anophthalmic sockets, there was a significant positive correlation between OSDI scores and TFO values (<jats:italic>p<\/jats:italic>\u2009=\u20090.007), between the grade of posterior blepharitis and TFO values (<jats:italic>p<\/jats:italic>\u2009=\u20090.026), and between the conjunctival inflammation and MMP-9 values (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), as well as between MMP-9 levels and time since eye loss (<jats:italic>p<\/jats:italic>\u2009=\u20090.004).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Measuring MMP-9 and TFO may be helpful tools as efficient, quantifiable biomarkers, disease course parameters, or predictors for treatment response in the clinical management of patients with DASS or future therapy studies. Ophthalmologists should consider the updated diagnosis criteria including TFO and the definition for DASS proposed in this study.<\/jats:p>\n                \n              <\/jats:sec>","DOI":"10.1007\/s00417-022-05895-0","type":"journal-article","created":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T04:31:13Z","timestamp":1668141073000},"page":"821-831","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Novel point-of-care biomarkers of the dry anophthalmic socket syndrome: tear film osmolarity and matrix metalloproteinase 9 immunoassay"],"prefix":"10.1007","volume":"261","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0224-3597","authenticated-orcid":false,"given":"Alexander C.","family":"Rokohl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katharina","family":"Wall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Trester","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philomena A.","family":"Wawer Matos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongwei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Werner","family":"Adler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith R.","family":"Pine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ludwig M.","family":"Heindl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,11,11]]},"reference":[{"key":"5895_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-021-01426-z","author":"AC Rokohl","year":"2021","unstructured":"Rokohl AC, Trester M, Naderi P, Loreck N, Zwingelberg S, Bucher F, Pine KR, Heindl LM (2021) Dry anophthalmic socket syndrome - morphological alterations in meibomian glands. Eye (Lond). https:\/\/doi.org\/10.1038\/s41433-021-01426-z","journal-title":"Eye (Lond)"},{"key":"5895_CR2","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.jtos.2020.05.001","volume":"18","author":"AC Rokohl","year":"2020","unstructured":"Rokohl AC, Trester M, Guo Y, Adler W, Jaeger VK, Loreck N, Mor JM, Pine KR, Heindl LM (2020) Dry anophthalmic socket syndrome - standardized clinical evaluation of symptoms and signs. Ocul Surf 18:453\u2013459. https:\/\/doi.org\/10.1016\/j.jtos.2020.05.001","journal-title":"Ocul Surf"},{"key":"5895_CR3","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1007\/s00417-018-3942-8","volume":"256","author":"AC Rokohl","year":"2018","unstructured":"Rokohl AC, Koch KR, Adler W, Trester M, Trester W, Pine NS, Pine KR, Heindl LM (2018) Concerns of anophthalmic patients-a comparison between cryolite glass and polymethyl methacrylate prosthetic eye wearers. Graefes Arch Clin Exp Ophthalmol 256:1203\u20131208. https:\/\/doi.org\/10.1007\/s00417-018-3942-8","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"5895_CR4","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1097\/IOP.0000000000001021","volume":"34","author":"AC Rokohl","year":"2018","unstructured":"Rokohl AC, Koch KR, Trester M, Trester W, Pine KR, Heindl LM (2018) Concerns of anophthalmic patients wearing cryolite glass prosthetic eyes. Ophthalmic Plast Reconstr Surg 34:369\u2013374. https:\/\/doi.org\/10.1097\/IOP.0000000000001021","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"5895_CR5","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1007\/s00417-019-04395-y","volume":"257","author":"AC Rokohl","year":"2019","unstructured":"Rokohl AC, Adler W, Koch KR, Mor JM, Jia R, Trester M, Pine NS, Pine KR, Heindl LM (2019) Cryolite glass prosthetic eyes-the response of the anophthalmic socket. Graefes Arch Clin Exp Ophthalmol 257:2015\u20132023. https:\/\/doi.org\/10.1007\/s00417-019-04395-y","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"5895_CR6","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1055\/a-0764-4974","volume":"236","author":"AC Rokohl","year":"2019","unstructured":"Rokohl AC, Mor JM, Trester M, Koch KR, Heindl LM (2019) Rehabilitation of anophthalmic patients with prosthetic eyes in germany today - supply possibilities, daily use, complications and psychological aspects. Klin Monbl Augenheilkd 236:54\u201362. https:\/\/doi.org\/10.1055\/a-0764-4974","journal-title":"Klin Monbl Augenheilkd"},{"key":"5895_CR7","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1080\/02713683.2020.1770294","volume":"45","author":"AC Rokohl","year":"2020","unstructured":"Rokohl AC, Trester M, Pine KR, Heindl LM (2020) Prevention of socket complications in anophthalmic patients. Curr Eye Res 45:1625\u20131626. https:\/\/doi.org\/10.1080\/02713683.2020.1770294","journal-title":"Curr Eye Res"},{"key":"5895_CR8","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s00417-020-04908-0","volume":"259","author":"LM Heindl","year":"2021","unstructured":"Heindl LM, Trester M, Guo Y, Zwiener F, Sadat N, Pine NS, Pine KR, Traweger A, Rokohl AC (2021) Anxiety and depression in patients wearing prosthetic eyes. Graefes Arch Clin Exp Ophthalmol 259:495\u2013503. https:\/\/doi.org\/10.1007\/s00417-020-04908-0","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"5895_CR9","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/S0161-6420(80)35266-4","volume":"87","author":"L Allen","year":"1980","unstructured":"Allen L, Kolder HE, Bulgarelli EM, Bulgarelli DM (1980) Artificial eyes and tear measurements. Ophthalmology 87:155\u2013157","journal-title":"Ophthalmology"},{"key":"5895_CR10","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1097\/ICU.0000000000000069","volume":"25","author":"E Bohman","year":"2014","unstructured":"Bohman E, Roed Rassmusen ML, Kopp ED (2014) Pain and discomfort in the anophthalmic socket. Curr Opin Ophthalmol 25:455\u2013460. https:\/\/doi.org\/10.1097\/ICU.0000000000000069","journal-title":"Curr Opin Ophthalmol"},{"key":"5895_CR11","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1136\/bjophthalmol-2012-302404","volume":"97","author":"SY Jang","year":"2013","unstructured":"Jang SY, Lee SY, Yoon JS (2013) Meibomian gland dysfunction in longstanding prosthetic eye wearers. Br J Ophthalmol 97:398\u2013402. https:\/\/doi.org\/10.1136\/bjophthalmol-2012-302404","journal-title":"Br J Ophthalmol"},{"issue":"602\u2013607","key":"5895_CR12","doi-asserted-by":"publisher","first-page":"e601","DOI":"10.1016\/j.ajo.2009.10.023","volume":"149","author":"SE Kim","year":"2010","unstructured":"Kim SE, Yoon JS, Lee SY (2010) Tear measurement in prosthetic eye users with fourier-domain optical coherence tomography. Am J Ophthalmol 149(602\u2013607):e601. https:\/\/doi.org\/10.1016\/j.ajo.2009.10.023","journal-title":"Am J Ophthalmol"},{"key":"5895_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/eye.2017.213","author":"JS Ko","year":"2017","unstructured":"Ko JS, Seo Y, Chae MK, Jang SY, Yoon JS (2017) Effect of topical loteprednol etabonate with lid hygiene on tear cytokines and meibomian gland dysfunction in prosthetic eye wearers. Eye (Lond). https:\/\/doi.org\/10.1038\/eye.2017.213","journal-title":"Eye (Lond)"},{"key":"5895_CR14","first-page":"59","volume":"8","author":"RI Noble","year":"1973","unstructured":"Noble RI, Hill JC, Webb C (1973) The dry socket\u2013a new lubricant (safflower oil). Can J Ophthalmol 8:59\u201362","journal-title":"Can J Ophthalmol"},{"key":"5895_CR15","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/j.1442-9071.2010.02381.x","volume":"39","author":"K Pine","year":"2011","unstructured":"Pine K, Sloan B, Stewart J, Jacobs RJ (2011) Concerns of anophthalmic patients wearing artificial eyes. Clin Exp Ophthalmol 39:47\u201352. https:\/\/doi.org\/10.1111\/j.1442-9071.2010.02381.x","journal-title":"Clin Exp Ophthalmol"},{"key":"5895_CR16","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1111\/cxo.12004","volume":"96","author":"KR Pine","year":"2013","unstructured":"Pine KR, Sloan B, Stewart J, Jacobs RJ (2013) The response of the anophthalmic socket to prosthetic eye wear. Clin Exp Optom 96:388\u2013393. https:\/\/doi.org\/10.1111\/cxo.12004","journal-title":"Clin Exp Optom"},{"key":"5895_CR17","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1038\/eye.2014.174","volume":"28","author":"JW Han","year":"2014","unstructured":"Han JW, Yoon JS, Jang SY (2014) Short-term effects of topical cyclosporine A 0.05% (restasis) in long-standing prosthetic eye wearers: a pilot study. Eye (Lond) 28:1212\u20131217. https:\/\/doi.org\/10.1038\/eye.2014.174","journal-title":"Eye (Lond)"},{"key":"5895_CR18","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1038\/s41433-020-01236-9","volume":"35","author":"Y Shapira","year":"2021","unstructured":"Shapira Y, Worrell E, Litwin AS, Malhotra R (2021) The UK national artificial eye questionnaire study: predictors of artificial eye wearers\u2019 experience part 1-comfort and satisfaction. Eye (Lond) 35:2233\u20132240. https:\/\/doi.org\/10.1038\/s41433-020-01236-9","journal-title":"Eye (Lond)"},{"key":"5895_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-021-01459-4","author":"Y Shapira","year":"2021","unstructured":"Shapira Y, Worrell E, Litwin AS, Malhotra R (2021) The UK national artificial eye questionnaire study: predictors of artificial eye wearers\u2019 experience part 2 - visual function and quality of life. Eye (Lond). https:\/\/doi.org\/10.1038\/s41433-021-01459-4","journal-title":"Eye (Lond)"},{"key":"5895_CR20","doi-asserted-by":"publisher","first-page":"4557","DOI":"10.1167\/iovs.09-4596","volume":"51","author":"M Suzuki","year":"2010","unstructured":"Suzuki M, Massingale ML, Ye F, Godbold J, Elfassy T, Vallabhajosyula M, Asbell PA (2010) Tear osmolarity as a biomarker for dry eye disease severity. Invest Ophthalmol Vis Sci 51:4557\u20134561. https:\/\/doi.org\/10.1167\/iovs.09-4596","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"5895_CR21","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/978-1-4615-2417-5_83","volume":"350","author":"RL Farris","year":"1994","unstructured":"Farris RL (1994) Tear osmolarity\u2013a new gold standard? Adv Exp Med Biol 350:495\u2013503. https:\/\/doi.org\/10.1007\/978-1-4615-2417-5_83","journal-title":"Adv Exp Med Biol"},{"key":"5895_CR22","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/s1542-0124(12)70157-x","volume":"3","author":"A Tomlinson","year":"2005","unstructured":"Tomlinson A, Khanal S (2005) Assessment of tear film dynamics: quantification approach. Ocul Surf 3:81\u201395. https:\/\/doi.org\/10.1016\/s1542-0124(12)70157-x","journal-title":"Ocul Surf"},{"key":"5895_CR23","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.jtos.2017.05.008","volume":"15","author":"JP Craig","year":"2017","unstructured":"Craig JP, Nichols KK, Akpek EK, Caffery B, Dua HS, Joo CK, Liu Z, Nelson JD, Nichols JJ, Tsubota K, Stapleton F (2017) TFOS DEWS II definition and classification report. Ocul Surf 15:276\u2013283. https:\/\/doi.org\/10.1016\/j.jtos.2017.05.008","journal-title":"Ocul Surf"},{"key":"5895_CR24","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.jtos.2017.05.011","volume":"15","author":"AJ Bron","year":"2017","unstructured":"Bron AJ, de Paiva CS, Chauhan SK, Bonini S, Gabison EE, Jain S, Knop E, Markoulli M, Ogawa Y, Perez V, Uchino Y, Yokoi N, Zoukhri D, Sullivan DA (2017) TFOS DEWS II pathophysiology report. Ocul Surf 15:438\u2013510. https:\/\/doi.org\/10.1016\/j.jtos.2017.05.011","journal-title":"Ocul Surf"},{"key":"5895_CR25","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.3109\/02713683.2014.906623","volume":"39","author":"D Yoon","year":"2014","unstructured":"Yoon D, Gadaria-Rathod N, Oh C, Asbell PA (2014) Precision and accuracy of TearLab osmometer in measuring osmolarity of salt solutions. Curr Eye Res 39:1247\u20131250. https:\/\/doi.org\/10.3109\/02713683.2014.906623","journal-title":"Curr Eye Res"},{"key":"5895_CR26","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1586\/erm.12.142","volume":"13","author":"P Versura","year":"2013","unstructured":"Versura P, Campos EC (2013) TearLab(R) osmolarity system for diagnosing dry eye. Expert Rev Mol Diagn 13:119\u2013129. https:\/\/doi.org\/10.1586\/erm.12.142","journal-title":"Expert Rev Mol Diagn"},{"key":"5895_CR27","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.jtos.2017.05.001","volume":"15","author":"JS Wolffsohn","year":"2017","unstructured":"Wolffsohn JS, Arita R, Chalmers R, Djalilian A, Dogru M, Dumbleton K, Gupta PK, Karpecki P, Lazreg S, Pult H, Sullivan BD, Tomlinson A, Tong L, Villani E, Yoon KC, Jones L, Craig JP (2017) TFOS DEWS II diagnostic methodology report. Ocul Surf 15:539\u2013574. https:\/\/doi.org\/10.1016\/j.jtos.2017.05.001","journal-title":"Ocul Surf"},{"key":"5895_CR28","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1167\/tvst.7.5.31","volume":"7","author":"JY Park","year":"2018","unstructured":"Park JY, Kim BG, Kim JS, Hwang JH (2018) Matrix metalloproteinase 9 point-of-care immunoassay result predicts response to topical cyclosporine treatment in dry eye disease. Transl Vis Sci Technol 7:31. https:\/\/doi.org\/10.1167\/tvst.7.5.31","journal-title":"Transl Vis Sci Technol"},{"key":"5895_CR29","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/s1542-0124(12)70148-9","volume":"2","author":"ME Stern","year":"2004","unstructured":"Stern ME, Pflugfelder SC (2004) Inflammation in dry eye. Ocul Surf 2:124\u2013130. https:\/\/doi.org\/10.1016\/s1542-0124(12)70148-9","journal-title":"Ocul Surf"},{"key":"5895_CR30","doi-asserted-by":"publisher","first-page":"4293","DOI":"10.1167\/iovs.03-1145","volume":"45","author":"L Luo","year":"2004","unstructured":"Luo L, Li DQ, Doshi A, Farley W, Corrales RM, Pflugfelder SC (2004) Experimental dry eye stimulates production of inflammatory cytokines and MMP-9 and activates MAPK signaling pathways on the ocular surface. Invest Ophthalmol Vis Sci 45:4293\u20134301. https:\/\/doi.org\/10.1167\/iovs.03-1145","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"5895_CR31","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.ophtha.2014.07.048","volume":"122","author":"P Aragona","year":"2015","unstructured":"Aragona P, Aguennouz M, Rania L, Postorino E, Sommario MS, Roszkowska AM, De Pasquale MG, Pisani A, Puzzolo D (2015) Matrix metalloproteinase 9 and transglutaminase 2 expression at the ocular surface in patients with different forms of dry eye disease. Ophthalmology 122:62\u201371. https:\/\/doi.org\/10.1016\/j.ophtha.2014.07.048","journal-title":"Ophthalmology"},{"key":"5895_CR32","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1097\/ICO.0000000000000175","volume":"33","author":"R Sambursky","year":"2014","unstructured":"Sambursky R, Davitt WF 3rd, Friedberg M, Tauber S (2014) Prospective, multicenter, clinical evaluation of point-of-care matrix metalloproteinase-9 test for confirming dry eye disease. Cornea 33:812\u2013818. https:\/\/doi.org\/10.1097\/ICO.0000000000000175","journal-title":"Cornea"},{"key":"5895_CR33","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1001\/jamaophthalmol.2013.561","volume":"131","author":"R Sambursky","year":"2013","unstructured":"Sambursky R, Davitt WF 3rd, Latkany R, Tauber S, Starr C, Friedberg M, Dirks MS, McDonald M (2013) Sensitivity and specificity of a point-of-care matrix metalloproteinase 9 immunoassay for diagnosing inflammation related to dry eye. JAMA Ophthalmol 131:24\u201328. https:\/\/doi.org\/10.1001\/jamaophthalmol.2013.561","journal-title":"JAMA Ophthalmol"},{"key":"5895_CR34","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.1016\/j.ophtha.2016.07.028","volume":"123","author":"EM Messmer","year":"2016","unstructured":"Messmer EM, von Lindenfels V, Garbe A, Kampik A (2016) Matrix metalloproteinase 9 testing in dry eye disease using a commercially available point-of-care immunoassay. Ophthalmology 123:2300\u20132308. https:\/\/doi.org\/10.1016\/j.ophtha.2016.07.028","journal-title":"Ophthalmology"},{"key":"5895_CR35","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1001\/archopht.118.5.615","volume":"118","author":"RM Schiffman","year":"2000","unstructured":"Schiffman RM, Christianson MD, Jacobsen G, Hirsch JD, Reis BL (2000) Reliability and validity of the ocular surface disease index. Arch Ophthalmol 118:615\u2013621. https:\/\/doi.org\/10.1001\/archopht.118.5.615","journal-title":"Arch Ophthalmol"},{"key":"5895_CR36","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/j.1444-0938.2012.00754.x","volume":"96","author":"KR Pine","year":"2013","unstructured":"Pine KR, Sloan B, Jacobs RJ (2013) The development of measurement tools for prosthetic eye research. Clin Exp Optom 96:32\u201338. https:\/\/doi.org\/10.1111\/j.1444-0938.2012.00754.x","journal-title":"Clin Exp Optom"},{"key":"5895_CR37","first-page":"29","volume":"125","author":"KR Pine","year":"2012","unstructured":"Pine KR, Sloan B, Jacobs RJ (2012) Biosocial profile of New Zealand prosthetic eye wearers. N Z Med J 125:29\u201338","journal-title":"N Z Med J"},{"key":"5895_CR38","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1080\/01676830.2017.1337201","volume":"36","author":"NS Pine","year":"2017","unstructured":"Pine NS, de Terte I, Pine KR (2017) An investigation into discharge, visual perception, and appearance concerns of prosthetic eye wearers. Orbit 36:401\u2013406. https:\/\/doi.org\/10.1080\/01676830.2017.1337201","journal-title":"Orbit"},{"key":"5895_CR39","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.2147\/OPTH.S254910","volume":"14","author":"NS Pine","year":"2020","unstructured":"Pine NS, Pine KR (2020) Depression, anxiety and stress indicators for prosthetic eye wearers. Clin Ophthalmol 14:1715\u20131723. https:\/\/doi.org\/10.2147\/OPTH.S254910","journal-title":"Clin Ophthalmol"},{"key":"5895_CR40","doi-asserted-by":"publisher","first-page":"1240537","DOI":"10.1155\/2019\/1240537","volume":"2019","author":"A Zaleska-Zmijewska","year":"2019","unstructured":"Zaleska-Zmijewska A, Strzemecka E, Wawrzyniak ZM, Szaflik JP (2019) Extracellular MMP-9-based assessment of ocular surface inflammation in patients with primary open-angle glaucoma. J Ophthalmol 2019:1240537. https:\/\/doi.org\/10.1155\/2019\/1240537","journal-title":"J Ophthalmol"},{"key":"5895_CR41","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.jfo.2019.01.006","volume":"42","author":"Y Maucourant","year":"2019","unstructured":"Maucourant Y, Ruesche V, Mouriaux F (2019) Evaluation of conjunctival inflammation among prosthesis wearers. J Fr Ophtalmol 42:696\u2013702. https:\/\/doi.org\/10.1016\/j.jfo.2019.01.006","journal-title":"J Fr Ophtalmol"},{"key":"5895_CR42","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/s1542-0124(12)70139-8","volume":"1","author":"GN Foulks","year":"2003","unstructured":"Foulks GN, Bron AJ (2003) Meibomian gland dysfunction: a clinical scheme for description, diagnosis, classification, and grading. Ocul Surf 1:107\u2013126. https:\/\/doi.org\/10.1016\/s1542-0124(12)70139-8","journal-title":"Ocul Surf"},{"key":"5895_CR43","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1136\/bjophthalmol-2015-307415","volume":"100","author":"C Baudouin","year":"2016","unstructured":"Baudouin C, Messmer EM, Aragona P, Geerling G, Akova YA, Benitez-del-Castillo J, Boboridis KG, Merayo-Lloves J, Rolando M, Labetoulle M (2016) Revisiting the vicious circle of dry eye disease: a focus on the pathophysiology of meibomian gland dysfunction. Br J Ophthalmol 100:300\u2013306. https:\/\/doi.org\/10.1136\/bjophthalmol-2015-307415","journal-title":"Br J Ophthalmol"},{"key":"5895_CR44","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.jtos.2017.04.001","volume":"15","author":"DA Sullivan","year":"2017","unstructured":"Sullivan DA, Rocha EM, Aragona P, Clayton JA, Ding J, Golebiowski B, Hampel U, McDermott AM, Schaumberg DA, Srinivasan S, Versura P, Willcox MDP (2017) TFOS DEWS II sex, gender, and hormones report. Ocul Surf 15:284\u2013333. https:\/\/doi.org\/10.1016\/j.jtos.2017.04.001","journal-title":"Ocul Surf"},{"key":"5895_CR45","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.jtos.2017.05.003","volume":"15","author":"F Stapleton","year":"2017","unstructured":"Stapleton F, Alves M, Bunya VY, Jalbert I, Lekhanont K, Malet F, Na KS, Schaumberg D, Uchino M, Vehof J, Viso E, Vitale S, Jones L (2017) TFOS DEWS II epidemiology report. Ocul Surf 15:334\u2013365. https:\/\/doi.org\/10.1016\/j.jtos.2017.05.003","journal-title":"Ocul Surf"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-022-05895-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-022-05895-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-022-05895-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,6]],"date-time":"2023-03-06T11:40:46Z","timestamp":1678102846000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-022-05895-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,11]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["5895"],"URL":"https:\/\/doi.org\/10.1007\/s00417-022-05895-0","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,11]]},"assertion":[{"value":"15 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee of the University of Auckland and of the University of Cologne and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and informed consent"}},{"value":"M. T. is the owner of the Trester-Institute for Ocular Prosthetics and Artificial Eyes. All other authors declare no competing interests. All authors have full control of all primary data, and they agree to allow <i>Eye<\/i> to review their data upon request.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}